Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesRecent advances in isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids of marine originHigh-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometryIndoleamine 2,3-dioxygenase controls fungal loads and immunity in Paracoccidioidomicosis but is more important to susceptible than resistant hosts.Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection.Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation.1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosisThe Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities.The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus.A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen.Mesenchymal Stromal Cells Are More Immunosuppressive In Vitro If They Are Derived from Endometriotic Lesions than from Eutopic Endometrium.Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling.Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.1-Methyl-D-tryptophan Reduces Tumor CD133+ cells, Wnt/β-catenin and NF-κβp65 while Enhances Lymphocytes NF-κβ2, STAT3, and STAT4 Pathways in Murine Pancreatic Adenocarcinoma.
P2860
Q21129356-54EC1485-E531-4A14-8E8B-C92473B8A4DCQ26801027-04C2744D-F266-4751-810A-60E503C9F4D8Q28650315-B9554FEE-6170-435F-A74C-E9ACBE847F0BQ35439002-7818FA33-03A6-4A30-BFF0-CE19C0F44712Q36005818-FEECCB2D-1224-40A7-905E-0585D7706CC1Q37479083-143F7603-66FA-4D5B-AAF6-013320A3F352Q37603455-E5B36B1A-A4A9-483A-B1B3-E74E6A303478Q38675915-6FB569C8-AB9B-4C5A-87E1-88E8114601F8Q42339159-E4FC2EF2-5E7C-4B25-9639-65A442B7544BQ42379001-718CCCC1-9E72-462E-86FC-ABB4977911C0Q46121081-13C9C625-3DC2-49EA-B1D2-2604E4338E4CQ47159936-61BBFCB3-11E0-4AD6-8611-5CCAEB106BCBQ47620767-58F60F6A-74BD-4CF5-8749-4FF7F117EB23Q48305650-C3850D16-E826-424D-89A0-37F93B9A8AC2Q55516059-F36E4200-4856-4EAB-83D0-7BB0D7067201
P2860
Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Persistent infectious diseases ...... and implications for therapy.
@en
type
label
Persistent infectious diseases ...... and implications for therapy.
@en
prefLabel
Persistent infectious diseases ...... and implications for therapy.
@en
P2860
P1476
Persistent infectious diseases ...... and implications for therapy.
@en
P2093
Heidi Barth
Sukanya Raghuraman
P2860
P304
P356
10.3109/1040841X.2012.742037
P407
P577
2012-11-23T00:00:00Z